CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Planned sale 10% owner sold 189,431 shares at an average $6.41 ($1,213,667)
- 4 Planned sale 10% owner sold 463,774 shares at an average $6.27 ($2,906,278)
- 4 Planned sale EVP & Chief Financial Officer sold 6,799 shares at $5.56 ($37,782)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 2,385 shares at $5.16 ($12,307)
- 4 Planned sale EVP and General Counsel sold 1,365 shares at $5.86 ($8,003)
- 4 Planned sale Director sold 22,000 shares at $5.64 ($124,047)
- 4 Planned sale 10% owner sold 24,553 shares at an average $6.50 ($159,655)
- 4 Planned sale 10% owner sold 113,099 shares at an average $6.01 ($679,870)
- 4 Planned sale 10% owner sold 298,649 shares at an average $6.07 ($1,812,378)
- 4 Planned sale 10% owner sold 330,210 shares at an average $6.23 ($2,058,247)
- 4 Planned sale 10% owner sold 29,515 shares at an average $6.08 ($179,563)
- 4 Planned sale 10% owner sold 251,360 shares at an average $6.14 ($1,543,899)
- 4 Planned sale 10% owner sold 538,375 shares at an average $5.99 ($3,223,939)
- 4 Planned sale 10% owner sold 524,297 shares at an average $5.57 ($2,922,426)
- 4 Planned sale Director sold 22,000 shares at $5.84 ($128,396)
- 4 Planned sale Director sold 22,000 shares at $4.99 ($109,811)
- 4 Planned sale Director sold 22,000 shares at $4.99 ($109,699)
- 4 Planned sale EVP and Chief Medical Officer sold 10,382 shares at an average $5.47 ($56,791)
- 4 Planned sale Director sold 22,000 shares at $5.10 ($112,207)
- 4 Other disposition Director disposed of 14,027 shares (other)
Page 3 of 25 · 491 filings